Results 41 to 50 of about 180,858 (308)

How big a problem is non-alcoholic fatty liver disease? [PDF]

open access: yes, 2011
This is one of a series of occasional articles that highlight areas of practice where management lacks convincing supporting ...
McPherson, Stuart   +5 more
core   +1 more source

The effect of  the  products of  ethanol metabolism on the  liver – a  review

open access: yesAlcoholism and Drug Addiction, 2019
The consequences of consuming excessive amounts of alcoholic beverages are currently an important problem for many societies, not only in the context of treatment of alcohol dependence, but also the health effects of alcohol abuse.
Aleksandra Kołota
doaj   +1 more source

Recurrent and de novo non-alcoholic steatohepatitis following orthotopic liver transplantation [PDF]

open access: yesArquivos de Gastroenterologia, 2001
Background — Non-alcoholic steatohepatitis was coined in 1980 to describe pathological and clinical features of non-alcoholic disease associated with pathological features, commonly seen in alcoholic-liver disease itself.
Raquel F. Liermann GARCIA   +5 more
doaj   +1 more source

Alcoholic liver disease

open access: yesWorld Journal of Hepatology, 2012
Alcohol use disorders affect millions of individuals worldwide. Alcohol consumption is directly associated with liver disease mortality and accounts for elevated social and economic costs. Alcoholic liver disease (ALD) may take the form of acute involvement (alcoholic hepatitis) or chronic liver disease (steatosis, steatohepatitis, fibrosis and ...
Radan, Bruha   +2 more
openaire   +2 more sources

Factors associated with nonalcoholic fatty liver disease grades detected by ultrasound at a screening center in Klang Valley, Malaysia.

open access: yesمجلة كلية الطب, 2018
Background: Non-alcoholic fatty liver disease (NAFLD) is a very common liver disease in the world, particularly in Western and developed countries. It is rapidly growing in the Asia- Pacific region.
Abdul Sattar A. Khammas   +7 more
doaj   +1 more source

Alcoholic Liver Disease

open access: yesMedical Clinics of North America, 1989
Alcohol has been implicated in the genesis of liver disease for centuries. Significant progress has been made in our understanding of the pathogenesis of ALD. It is now apparent that both the consumption and the metabolism of alcohol promote the production of inflammatory mediators (cytokines) that result in hepatotoxicity and fibrogenesis.
openaire   +3 more sources

Macrophage Activation in Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) Correlates with Hepatic Progenitor Cell Response via Wnt3a Pathway. [PDF]

open access: yesPLoS ONE, 2016
Non-alcoholic fatty liver disease is one of the most important causes of liver-related morbidity in children. In non-alcoholic fatty liver disease, the activation of liver resident macrophage pool is a central event in the progression of liver injury ...
Guido Carpino   +10 more
doaj   +1 more source

ALCOHOLIC LIVER DISEASE: ISSUES OF ETIOLOGY AND THE IMPACT OF RISK FACTORS (LITERATURE REVIEW)

open access: yesБайкальский медицинский журнал, 2023
Alcohol consumption is one of the main causes leading to chronic liver disease. Alcoholic liver disease is a set of cascading events, consisting first of alcoholic hepatic steatosis and then mainly through alcoholic steatohepatitis, leading to cirrhosis ...
Daria A. Stepanenko   +2 more
doaj   +1 more source

Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes

open access: yes, 2013
BackgroundThe relationship between non-alcoholic fatty liver disease (NAFLD) and atrial fibrillation (AF) in type 2 diabetes is currently unknown. We examined the relationship between NAFLD and risk of incident AF in people with type 2 diabetes.Methods ...
Zoppini Giacomo   +39 more
core   +1 more source

Farewell to the term ‘non-alcoholic fatty liver disease’

open access: yes, 2023
After years of debate, the nomenclature non-alcoholic fatty liver disease (NAFLD) has been changed to metabolic dysfunction–associated steatotic liver disease, or MASLD (figure 1).
Mortimore, G.
core  

Home - About - Disclaimer - Privacy